What to expect in the Immunome Inc. interview process

Based on publicly available sources, Immunome, Inc. is a clinical-stage targeted oncology biotechnology company headquartered in Bothell, Washington, with an additional office in Exton, Pennsylvania, and a globally distributed workforce across the United States, Israel, Netherlands, and Canada.

Public data indicates that the company has experienced rapid internal growth, expanding its workforce to roughly 172 to over 200 employees—reflecting a year-over-year increase of roughly 60% to 93%. Despite this workforce expansion, Immunome operates with a modest annual revenue footprint reported between approximately $1.0M and $10M ($6.9M to $8.5M), alongside a market cap in the $800M–$900M range and total funding reaching $93.9M.

Regarding compensation and role leveling, salary estimates from job postings highlight significant variance depending on seniority. For instance, mid-to-senior technical roles like Senior Manager of Analytical Development range from $172,331 to $194,174, while leadership positions such as Senior Director of Global Market span $236,650 to $320,791, and Senior Director of Clinical Development commands $342,561 to $389,125 per year.

Employer branding and leadership visibility—including statements from CEO Dr. Clay Siegall and internal employee shout-outs—heavily emphasize a patient-centric mission focused on advancing oncology therapeutics, such as their Phase 3 program varegacestat, Phase 1 asset IM-1021, and various preclinical radioligand and ADC candidates. However, independent day-to-day internal operational details, formal return-to-office mandates, and specific interview mechanics remain largely unaddressed in public records.